Lower plasma collection weighs on profitability
13/08/20 -"Population confinement measures adversely impacted plasma collection volumes (especially in the US), leading to higher plasma collection costs and thereby lower profits in H1. Given that such ..."
Pages
65
Language
English
Published on
13/08/20
You may also be interested by these reports :
17/09/20
Since our last Teaser in May 2019, it has been a rollercoaster ride for Grifols (Buy, Spain), a leading player in the $23bn oligopolistic plasma ...
17/09/20
Merck confirmed our positive view on the company. As expected, management confirmed the FY 2022 guidance and put some nice colour on 2021. The ...
09/09/20
In line with its strategy of expanding its focus on the immuno-oncology space and strengthening its internal R&D pipeline, Sanofi has spent €5.2bn on ...
07/09/20
Surprisingly, Akebia’s oral HIF-PHI drug, Vadadustat, has shown heart safety concerns in a phase III study for non-dialysis CKD-anaemic patients. ...